EcoDrugPlus


Synonyms	1-vinyl-2-pyrrolidinone polymer E-1201 INS NO.1201 INS-1201 K30 K90) Kollidon 25, 30, 12pf, 17pf, 90f NSC-114022 NSC-142693 Plasdone Polyvidone Polyvinylpyrrolidone Polyvinylpyrrolidone (k25 Polyvinylpyrrolidone [k25, k30, k90] Polyvinylpyrrolidone-(1201) Povidone Povidone, unspecified Povidones Povidonum Vinisil
Status
Molecule Category	UNKNOWN
UNII	FZ989GH94E

Synonyms

1-vinyl-2-pyrrolidinone polymer

E-1201

INS NO.1201

INS-1201

K30

K90)

Kollidon 25, 30, 12pf, 17pf, 90f

NSC-114022

NSC-142693

Plasdone

Polyvidone

Polyvinylpyrrolidone

Polyvinylpyrrolidone (k25

Polyvinylpyrrolidone [k25, k30, k90]

Polyvinylpyrrolidone-(1201)

Povidone

Povidone, unspecified

Povidones

Povidonum

Vinisil

Status

Molecule Category

UNKNOWN

UNII

FZ989GH94E


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Resources	Reference
ChEMBL	CHEMBL2108139
FDA SRS	FZ989GH94E

Resources

Reference

ChEMBL

CHEMBL2108139

FDA SRS

FZ989GH94E


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

POVIDONE

Cross References